Winningham Rick E 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Winningham Rick E（CIK 1302443）在 2 家公司共报告 25 笔 SEC Form 4 内部人交易（最近一笔 2026-09-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 151,875 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 1.4M | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 76,875 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 23,400 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 92,567 | $0 |
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 卖出 | 1,692 | $408,432 |
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 卖出 | 14 | $3,425 |
| 2026-08-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 20,034 | $339,576 |
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 买入 | 1,605 | $0 |
| 2026-05-27 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 买入 | 3,415 | $471,543 |
| 2026-05-27 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 卖出 | 2,741 | $662,143 |
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 20,038 | $331,629 |
| 2026-04-03 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 买入 | 75,000 | $0 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 74,975 | $1.5M |
| 2025-11-21 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 买入 | 9,900 | $0 |
| 2025-11-21 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 56,817 | $1.0M |
| 2025-11-21 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 9,900 | $0 |
| 2025-11-20 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 卖出 | 5,500 | $994,730 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 15,394 | $206,126 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 买入 | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | 董事 | 卖出 | 1,805 | $200,806 |
| 2025-06-25 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 20,000 | $0 |
| 2025-06-17 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 9,600 | $0 |
| 2025-06-17 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 买入 | 9,600 | $0 |
| 2025-05-22 | Theravance Biopharma, Inc. (TBPH) | CHIEF EXECUTIVE OFFICER | 卖出 | 15,364 | $145,190 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24